FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061067939> ?p ?o ?g. }

• W2061067939 endingPage "95" @default.
• W2061067939 startingPage "89" @default.
• W2061067939 abstract "PROBLEM: Previous studies demonstrated that unique tissue-specific antigens expressed on vascular endothelial cells can serve as immunogens, and the apparent association between transplant rejection and antiendothelial cell (EC) antibodies is well established. A common feature of some placentas from women with recurrent pregnancy loss is the diffuse formation of microthrombi associated with changes in thromboresistant properties of endothelial cells, similar to the findings in rejected organs. Therefore, the prevalence of anti-EC antibodies in patients with recurrent pregnancy loss and the role of these antibodies in cultured human endothelial cells from umbilical cord vein were studied. METHOD OF STUDY: To evaluate the frequency of anti-EC antibodies, sera from 160 nonpregnant patients with recurrent pregnancy loss after absorption with pooled platelets and pooled leukocytes were tested using cultured human umbilical cord vein endothelial cells (HUVEC) by flow cytometry. To study the role of anti-EC antibodies, purified anti-EC IgGs were added to HUVEC cultures and hemostatic, fibrinolytic, and anticoagulation pathway markers (tissue factor, tissue plasminogen activator, palsminogen-activator inhibitor, thrombomodulin, heparan-sulfate proteoglican, antithrombin III, von Willebrand factor, CD54, human leukocyte antigens-DR, and transferin receptor) were detected by specific antibodies and flow cytometry. Immunoblotting analyses were done by using purified anti-EC IgGs against cell membrane proteins from endothelial cells and leukocytes extracted by detergent solubilization. RESULTS: Thirty-nine (24%) of the patients were positive for EC antibodies. Antipaternal lymphocyte antibodies were tested as well and were found in 37 (23%) of the patients as 25 sera (15.6%) showed reactivity with both EC and lymphocytes. Certain patient sera were reactive with HUVEC lines from some but not other umbilical cords, which suggests allotype Sera from 70 normal healthy male and nonpregnant female controls did not react with any of the individual HUVEC lines used. The purified anti-EC immunoglobulin G (IgGs) recognized bands, from HUVEC surface membrane protein preparations, with molecular weights of 120 kDa. Both hemostatic and fibrinolytic pathway markers were found activated in the presence of anti-EC IgGs, suggesting an altered endothelial cell surface activation state. CONCLUSIONS: The results indicate that anti-EC antibody is another marker for a subset of recurrent spontaneous aborters who may have activation of hemostasis and fibrinolysis as a mechanism involved in their losses." @default.
• W2061067939 created "2016-06-24" @default.
• W2061067939 creator A5001955282 @default.
• W2061067939 creator A5026912968 @default.
• W2061067939 creator A5033645498 @default.
• W2061067939 creator A5091179367 @default.
• W2061067939 date "1998-02-01" @default.
• W2061067939 modified "2023-09-27" @default.
• W2061067939 title "Anti-Endothelial Cell Antibodies: Another Cause for Pregnancy Loss?" @default.
• W2061067939 cites W125943306 @default.
• W2061067939 cites W1965551695 @default.
• W2061067939 cites W1968491565 @default.
• W2061067939 cites W1976540927 @default.
• W2061067939 cites W1977614936 @default.
• W2061067939 cites W1980952325 @default.
• W2061067939 cites W1996147320 @default.
• W2061067939 cites W1996379158 @default.
• W2061067939 cites W2009374872 @default.
• W2061067939 cites W2013551036 @default.
• W2061067939 cites W2024650125 @default.
• W2061067939 cites W2033935240 @default.
• W2061067939 cites W2049081612 @default.
• W2061067939 cites W2061318385 @default.
• W2061067939 cites W2085889060 @default.
• W2061067939 cites W2137141032 @default.
• W2061067939 cites W2157603347 @default.
• W2061067939 cites W2266979339 @default.
• W2061067939 cites W2418333827 @default.
• W2061067939 cites W4238711802 @default.
• W2061067939 cites W4243231151 @default.
• W2061067939 doi "https://doi.org/10.1111/j.1600-0897.1998.tb00340.x" @default.
• W2061067939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9506207" @default.
• W2061067939 hasPublicationYear "1998" @default.
• W2061067939 type Work @default.
• W2061067939 sameAs 2061067939 @default.
• W2061067939 citedByCount "13" @default.
• W2061067939 countsByYear W20610679392014 @default.
• W2061067939 countsByYear W20610679392015 @default.
• W2061067939 countsByYear W20610679392017 @default.
• W2061067939 countsByYear W20610679392018 @default.
• W2061067939 countsByYear W20610679392021 @default.
• W2061067939 crossrefType "journal-article" @default.
• W2061067939 hasAuthorship W2061067939A5001955282 @default.
• W2061067939 hasAuthorship W2061067939A5026912968 @default.
• W2061067939 hasAuthorship W2061067939A5033645498 @default.
• W2061067939 hasAuthorship W2061067939A5091179367 @default.
• W2061067939 hasConcept C123012128 @default.
• W2061067939 hasConcept C126322002 @default.
• W2061067939 hasConcept C147483822 @default.
• W2061067939 hasConcept C153911025 @default.
• W2061067939 hasConcept C159654299 @default.
• W2061067939 hasConcept C16685009 @default.
• W2061067939 hasConcept C186738567 @default.
• W2061067939 hasConcept C201267052 @default.
• W2061067939 hasConcept C202751555 @default.
• W2061067939 hasConcept C203014093 @default.
• W2061067939 hasConcept C2777292125 @default.
• W2061067939 hasConcept C2777411675 @default.
• W2061067939 hasConcept C2778382381 @default.
• W2061067939 hasConcept C55493867 @default.
• W2061067939 hasConcept C71924100 @default.
• W2061067939 hasConcept C86803240 @default.
• W2061067939 hasConcept C89560881 @default.
• W2061067939 hasConceptScore W2061067939C123012128 @default.
• W2061067939 hasConceptScore W2061067939C126322002 @default.
• W2061067939 hasConceptScore W2061067939C147483822 @default.
• W2061067939 hasConceptScore W2061067939C153911025 @default.
• W2061067939 hasConceptScore W2061067939C159654299 @default.
• W2061067939 hasConceptScore W2061067939C16685009 @default.
• W2061067939 hasConceptScore W2061067939C186738567 @default.
• W2061067939 hasConceptScore W2061067939C201267052 @default.
• W2061067939 hasConceptScore W2061067939C202751555 @default.
• W2061067939 hasConceptScore W2061067939C203014093 @default.
• W2061067939 hasConceptScore W2061067939C2777292125 @default.
• W2061067939 hasConceptScore W2061067939C2777411675 @default.
• W2061067939 hasConceptScore W2061067939C2778382381 @default.
• W2061067939 hasConceptScore W2061067939C55493867 @default.
• W2061067939 hasConceptScore W2061067939C71924100 @default.
• W2061067939 hasConceptScore W2061067939C86803240 @default.
• W2061067939 hasConceptScore W2061067939C89560881 @default.
• W2061067939 hasIssue "2" @default.
• W2061067939 hasLocation W20610679391 @default.
• W2061067939 hasLocation W20610679392 @default.
• W2061067939 hasOpenAccess W2061067939 @default.
• W2061067939 hasPrimaryLocation W20610679391 @default.
• W2061067939 hasRelatedWork W1521054430 @default.
• W2061067939 hasRelatedWork W1983830770 @default.
• W2061067939 hasRelatedWork W2004657066 @default.
• W2061067939 hasRelatedWork W2023748190 @default.
• W2061067939 hasRelatedWork W2130426857 @default.
• W2061067939 hasRelatedWork W2155219561 @default.
• W2061067939 hasRelatedWork W2380878202 @default.
• W2061067939 hasRelatedWork W2417006901 @default.
• W2061067939 hasRelatedWork W4242338177 @default.
• W2061067939 hasRelatedWork W3022292118 @default.
• W2061067939 hasVolume "39" @default.
• W2061067939 isParatext "false" @default.
• W2061067939 isRetracted "false" @default.

• next